Xuekun Wu

Also affiliated with Institute for Stem Cell Biology and Regenerative Medicine, Stanford University

MedicineBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option”.

Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option

European Heart Journal(2023)10.1093/eurheartj/ehad058

N/A

0DataRank · unranked

1 citations

Francesca Vacante, Joseph C. Wu, Xuekun Wu

Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target

Cell(2024)10.1016/j.cell.2024.09.034

N/A

0DataRank · unranked

70 citations

Phung N. Thai, Rabindra V. Shivnaraine, Lu Ren, Xuekun Wu, Dirk H. Siepe +12 more

Clinical trials in-a-dish for cardiovascular medicine

European Heart Journal(2024)10.1093/eurheartj/ehae519

N/A

0DataRank · unranked

32 citations

Kyle Swanson, Zehra Yıldırım, Wenqiang Liu, Ronglih Liao, Joseph C. Wu +1 more

Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish

The Annual Review of Pharmacology and Toxicology(2024)10.1146/annurev-pharmtox-022724-095035

N/A

0DataRank · unranked

27 citations

Kyle Swanson, Xuekun Wu, James Zou, Joseph C. Wu, Zehra Yıldırım

Cardiac fibrosis: from mechanisms and models to medicines

Trends in Pharmacological Sciences(2025)10.1016/j.tips.2025.07.016

N/A

0DataRank · unranked

13 citations

Xuekun Wu, Wenshu Zeng, Mark Chandy, Joseph C. Wu, Wenqiang Liu